OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals products. The company's product portfolio includes 4K score test used for diagnosis of prostate cancer; Rayaldee (calcifediol), an extended-release capsule for treatment of secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease; and the Claros analyzer, a blood performance test. OPKO develops products using proprietary technologies including, Carboxyl Terminal Peptide (CTP) technology, and AntagoNAT technology. It is advancing pipeline products targeted for the treatment of hypophosphatemia, obesity, diabetes, haemophilia, growth hormone deficiency, dravet syndrome and other diseases. It also offers veterinary products. The company has operational presence with offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OPKO Health Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- OPKO Health Inc Company Overview
- OPKO Health Inc Company Snapshot
- OPKO Health Inc Pipeline Products and Ongoing Clinical Trials Overview
- OPKO Health Inc - Pipeline Analysis Overview
- Business Description
- OPKO Health Inc - Key Facts
- OPKO Health Inc - Major Products and Services
- OPKO Health Inc Pipeline Products by Development Stage
- OPKO Health Inc Pipeline Products Overview
- Aquashunt
- Aquashunt Product Overview
- Claros 1 - Lyme Disease
- Claros 1 - Lyme Disease Product Overview
- Claros 1 - Women's Health
- Claros 1 - Women's Health Product Overview
- Claros 1 Analyzer - Cardiovascular Diseases
- Claros 1 Analyzer - Cardiovascular Diseases Product Overview
- Claros 1 Analyzer - Testosterone Assay
- Claros 1 Analyzer - Testosterone Assay Product Overview
- Claros 1 Analyzer - Vitamin D Test
- Claros 1 Analyzer - Vitamin D Test Product Overview
- Diagnostic Assay - CTnl
- Diagnostic Assay - CTnl Product Overview
- Diagnostic Assay - Fertility
- Diagnostic Assay - Fertility Product Overview
- Diagnostic Assay - Pre-term Bleed
- Diagnostic Assay - Pre-term Bleed Product Overview
- Diagnostic Assay - TSH
- Diagnostic Assay - TSH Product Overview
- Diagnostic Test - Multiple Sclerosis
- Diagnostic Test - Multiple Sclerosis Product Overview
- Diagnostic Test - Non-Small Cell Lung Cancer
- Diagnostic Test - Non-Small Cell Lung Cancer Product Overview
- Diagnostic Test - Pancreatic Cancer
- Diagnostic Test - Pancreatic Cancer Product Overview
- Diagnostic Test - Parkinson's Disease
- Diagnostic Test - Parkinson's Disease Product Overview
- Diagnostic Test - Tuberculosis
- Diagnostic Test - Tuberculosis Product Overview
- Diagnostic Test - Type 1 Diabetes
- Diagnostic Test - Type 1 Diabetes Product Overview
- Enko 1
- Enko 1 Product Overview
- Harmony Prenatal Test
- Harmony Prenatal Test Product Overview
- Inspiromatic
- Inspiromatic Product Overview
- mChip - Herpes
- mChip - Herpes Product Overview
- mChip - Malaria
- mChip - Malaria Product Overview
- OPKO Health Inc - Key Competitors
- OPKO Health Inc - Key Employees
- OPKO Health Inc - Key Employee Biographies
- OPKO Health Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- OPKO Health Inc, Recent Developments
- Mar 10, 2022: 9am.health offers affordable, convenient, at-home laboratory testing through Bioreference Laboratories
- Jan 21, 2022: OPKO Health : Retiring of Dr. Robert Fishel as Board of Director
- Nov 29, 2021: BioReference Laboratories announces readiness for COVID-19 testing if the Omicron COVID-19 Variant emerges in the U.S.
- Jul 29, 2021: OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results
- Jul 20, 2021: OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
- Mar 26, 2021: BioReference Laboratories expands COVID-19 school testing program
- Feb 22, 2021: New York State partners with BioReference Laboratories to spearhead the NY forward COVID-19 rapid test program to help reopen the New York economy
- Feb 18, 2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
- Jan 26, 2021: OPKO Health’s GeneDx adds repeat expansion analysis genetic tests for diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and other common forms of Hereditary Ataxia
- Jan 13, 2021: OPKO Health's BioReference Laboratories introduces Scarlet Health, an in-home diagnostic service to expand digital health access
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- OPKO Health Inc Pipeline Products and Ongoing Clinical Trials Overview
- OPKO Health Inc Pipeline Products by Equipment Type
- OPKO Health Inc Pipeline Products by Indication
- OPKO Health Inc, Key Facts
- OPKO Health Inc, Major Products and Services
- OPKO Health Inc Number of Pipeline Products by Development Stage
- OPKO Health Inc Pipeline Products Summary by Development Stage
- Aquashunt - Product Status
- Aquashunt - Product Description
- Claros 1 - Lyme Disease - Product Status
- Claros 1 - Lyme Disease - Product Description
- Claros 1 - Women's Health - Product Status
- Claros 1 - Women's Health - Product Description
- Claros 1 Analyzer - Cardiovascular Diseases - Product Status
- Claros 1 Analyzer - Cardiovascular Diseases - Product Description
- Claros 1 Analyzer - Testosterone Assay - Product Status
- Claros 1 Analyzer - Testosterone Assay - Product Description
- Claros 1 Analyzer - Vitamin D Test - Product Status
- Claros 1 Analyzer - Vitamin D Test - Product Description
- Diagnostic Assay - CTnl - Product Status
- Diagnostic Assay - CTnl - Product Description
- Diagnostic Assay - Fertility - Product Status
- Diagnostic Assay - Fertility - Product Description
- Diagnostic Assay - Pre-term Bleed - Product Status
- Diagnostic Assay - Pre-term Bleed - Product Description
- Diagnostic Assay - TSH - Product Status
- Diagnostic Assay - TSH - Product Description
- Diagnostic Test - Multiple Sclerosis - Product Status
- Diagnostic Test - Multiple Sclerosis - Product Description
- Diagnostic Test - Non-Small Cell Lung Cancer - Product Status
- Diagnostic Test - Non-Small Cell Lung Cancer - Product Description
- Diagnostic Test - Pancreatic Cancer - Product Status
- Diagnostic Test - Pancreatic Cancer - Product Description
- Diagnostic Test - Parkinson's Disease - Product Status
- Diagnostic Test - Parkinson's Disease - Product Description
- Diagnostic Test - Tuberculosis - Product Status
- Diagnostic Test - Tuberculosis - Product Description
- Diagnostic Test - Type 1 Diabetes - Product Status
- Diagnostic Test - Type 1 Diabetes - Product Description
- Enko 1 - Product Status
- Enko 1 - Product Description
- Harmony Prenatal Test - Product Status
- Harmony Prenatal Test - Product Description
- Inspiromatic - Product Status
- Inspiromatic - Product Description
- mChip - Herpes - Product Status
- mChip - Herpes - Product Description
- mChip - Malaria - Product Status
- mChip - Malaria - Product Description
- OPKO Health Inc, Key Employees
- OPKO Health Inc, Key Employee Biographies
- OPKO Health Inc, Other Locations
- OPKO Health Inc, Subsidiaries
- Glossary
- OPKO Health Inc Pipeline Products by Equipment Type
- OPKO Health Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novartis AG
- Laboratory Corp of America Holdings
- Siemens Healthineers AG
- Celgene Corp
- Quest Diagnostics Inc
- Ascendis Pharma AS
